Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Adbiotech Co., Ltd. (179530:KRX), powered by AI.
Adbiotech Co., Ltd. is currently trading at ₩2,260. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Adbiotech Co., Ltd. on Alpha Lenz.
Adbiotech Co., Ltd.'s P/E ratio is -18.4.
“Adbiotech Co., Ltd. trades at a P/E of -18.4 (undervalued) with modest ROE of -32.8%.”
Ask for details →Adbiotech Co., Ltd. is a prominent player in the biotechnology sector, specializing in the development and production of innovative products for animal health care. Primarily focused on advancing veterinary medicine, Adbiotech offers a diverse range of vaccines, diagnostic kits, and pharmaceutical formulations aimed at improving animal well-being and productivity. Their products cater to the needs of livestock, poultry, and domestic pets, ensuring robust health and disease prevention across these segments. Adbiotech operates in a critical industry that bridges agricultural productivity and public health, playing a vital role in maintaining the safety of animal-derived food products. The company's commitment to cutting-edge research and development has positioned it as a leader in animal biosciences. Through its activities, Adbiotech supports sectors such as agriculture and food production, emphasizing the importance of sustainable and safe practices. Within the financial market, it serves as a representation of the growing biotechnology field, attracting attention for its role in enhancing veterinary healthcare solutions and fostering advancements in biotechnology applications.
“Adbiotech Co., Ltd. trades at a P/E of -18.4 (undervalued) with modest ROE of -32.8%.”
Ask for details →Adbiotech Co., Ltd. (ticker: 179530) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 59 employees. Market cap is $60.9B.
The current price is ₩2,260 with a P/E ratio of -18.43x and P/B of 3.97x.
ROE is -32.78% and operating margin is -27.14%. Annual revenue is $12.9B.